No approval for Covaxin, expert panel seeks more data from Bharat Biotech
Friday, 1 January 2021 The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for grant of emergency use approval and has asked for more information, top sources said.
While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella said, "COVAXIN has shown less than 10% adverse reactions, while others have 60-70% adverse reactions. AstraZeneca...
The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get..
Connected TV has come a long way - but it still has a little way to go to fully realize the dreams of efficient, data-driven advertising that reaches individual homes. EMarketer forecasts US connected..
Covaxin maker Bharat Biotech has issued a fact sheet which details which categories of people should not be administered with the vaccine or which groups should take the vaccine with caution. Watch the..